ZHENGYU BIOTECHNOLOGY

ZHENGYU BIOTECHNOLOGY (Hainan) Co., Ltd., established in 2022, is a high-tech enterprise integrating product research and development, registration, production, and application. It shoulders the growing domestic and international production demands of Hengyu Biopharmaceutical and the company's international strategic layout. ZHENGYU BIOTECHNOLOGY operates modern production lines in accordance with GMP standards; equipped with standardized production workshops; an annual production capacity of 1 billion units, including the R&D and production of dosage forms such as patches, sprays, gels, creams, and pre-filled syringes, with an annual production capability exceeding 40 million units; upgraded to B+A grade facilities, fully ensuring the production requirements and capabilities for Class I, II, and III medical device products. The company also has a research and development experimental platform, covering preparation and purification laboratories, pharmaceutical formulation laboratories, pharmaceutical analysis laboratories, pharmacology laboratories, and other functions related to product formulation R&D and experimentation. Focused on the import and export of PDRN/PN international high-end medical devices, product manufacturing, qualification approvals, and the localization of internationally innovative products, ZHENGYU BIOTECHNOLOGY is currently taking the lead in striving for the registration and filing of PDRN/PN as a Class III medical device.